A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs
about
sameAs
A fundamental relationship between hydrophobic properties and biological activity for the duocarmycin class of DNA-alkylating antitumor drugs: hydrophobic-binding-driven bonding.Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.A five-membered lactone prodrug of CBI-based analogs of the duocarmycinsA novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct.Efficacious cyclic N-acyl O-amino phenol duocarmycin prodrugs.Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release
P2860
A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@ast
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@en
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@nl
type
label
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@ast
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@en
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@nl
prefLabel
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@ast
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@en
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@nl
P2093
P1476
A strategy for tumor-selective ...... vatives from nontoxic prodrugs
@en
P2093
P304
P356
10.1016/S0968-0896(01)00098-0
P407
P577
2001-07-01T00:00:00Z